Correlation Between Aclaris Therapeutics and IDEXX Laboratories
Can any of the company-specific risk be diversified away by investing in both Aclaris Therapeutics and IDEXX Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aclaris Therapeutics and IDEXX Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aclaris Therapeutics and IDEXX Laboratories, you can compare the effects of market volatilities on Aclaris Therapeutics and IDEXX Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aclaris Therapeutics with a short position of IDEXX Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aclaris Therapeutics and IDEXX Laboratories.
Diversification Opportunities for Aclaris Therapeutics and IDEXX Laboratories
-0.75 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aclaris and IDEXX is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Aclaris Therapeutics and IDEXX Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IDEXX Laboratories and Aclaris Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aclaris Therapeutics are associated (or correlated) with IDEXX Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IDEXX Laboratories has no effect on the direction of Aclaris Therapeutics i.e., Aclaris Therapeutics and IDEXX Laboratories go up and down completely randomly.
Pair Corralation between Aclaris Therapeutics and IDEXX Laboratories
Given the investment horizon of 90 days Aclaris Therapeutics is expected to generate 3.8 times more return on investment than IDEXX Laboratories. However, Aclaris Therapeutics is 3.8 times more volatile than IDEXX Laboratories. It trades about 0.02 of its potential returns per unit of risk. IDEXX Laboratories is currently generating about 0.01 per unit of risk. If you would invest 1,565 in Aclaris Therapeutics on August 24, 2024 and sell it today you would lose (1,133) from holding Aclaris Therapeutics or give up 72.4% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 99.8% |
Values | Daily Returns |
Aclaris Therapeutics vs. IDEXX Laboratories
Performance |
Timeline |
Aclaris Therapeutics |
IDEXX Laboratories |
Aclaris Therapeutics and IDEXX Laboratories Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Aclaris Therapeutics and IDEXX Laboratories
The main advantage of trading using opposite Aclaris Therapeutics and IDEXX Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aclaris Therapeutics position performs unexpectedly, IDEXX Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IDEXX Laboratories will offset losses from the drop in IDEXX Laboratories' long position.Aclaris Therapeutics vs. Neogen | Aclaris Therapeutics vs. Qiagen NV | Aclaris Therapeutics vs. Sotera Health Co | Aclaris Therapeutics vs. RadNet Inc |
IDEXX Laboratories vs. Waters | IDEXX Laboratories vs. IQVIA Holdings | IDEXX Laboratories vs. Charles River Laboratories | IDEXX Laboratories vs. Revvity |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stocks Directory Find actively traded stocks across global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |